1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Peter Brett, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label Neoadjuvant Pembrolizumab Plus Cetuximab in Betel Nut-Associated Locally Advanced Oral Cavity Squamous Cell Carcinoma Pembrolizumab and cetuximab - Betel-nut-associated Oral Carcinoma | Phase 2 | Not yet recruiting | Peter Brett, MD | 20 | 2026-08-15 | 2026-08-10 |
Cetuximab (1) · pembrolizumab (1)
Northern Mariana Islands (1)